Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
February 17, 1999
Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases
H N Lode, T Moehler, R Xiang, et al.
Cancer Letters
|
July 26, 2003
Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastoma
B Lange, U Schroeder, N Huebener, et al.
Cancer Research
|
August 17, 2001
Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma
A G Niethammer, R Xiang, J M Ruehlmann, et al.
Cancer Letters
|
July 26, 2003
Neuroblastoma directed therapy by a rational prodrug design of etoposide as a substrate for tyrosine hydroxylase
J Jikai, M Shamis, N Huebener, et al.
The Journal of Hospital Infection
|
February 21, 2012
Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies
M J Dümichen, K Seeger, H N Lode, et al.
BMC Pregnancy and Childbirth
|
July 31, 2016
The impact of socioeconomic factors on the efficiency of voluntary toxoplasmosis screening during pregnancy: a population-based study
A E Lange, J R Thyrian, S Wetzka, et al.
Cancer Letters
|
July 26, 2003
Vaccination with minigenes encoding for novel 'self' antigens are effective in DNA-vaccination against neuroblastoma
N Huebener, B Lange, C Lemmel, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 10, 2001
A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice
R Xiang, F J Primus, J M Ruehlmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2001
Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice
R Xiang, S Silletti, H N Lode, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 26, 2000
An autologous oral DNA vaccine protects against murine melanoma
R Xiang, H N Lode, T H Chao, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Proceedings of the National Academy of Sciences of the United States of America
|
February 17, 1999
Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases
H N Lode, T Moehler, R Xiang, et al.
Cancer Letters
|
July 26, 2003
Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastoma
B Lange, U Schroeder, N Huebener, et al.
Cancer Research
|
August 17, 2001
Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma
A G Niethammer, R Xiang, J M Ruehlmann, et al.
Cancer Letters
|
July 26, 2003
Neuroblastoma directed therapy by a rational prodrug design of etoposide as a substrate for tyrosine hydroxylase
J Jikai, M Shamis, N Huebener, et al.
The Journal of Hospital Infection
|
February 21, 2012
Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies
M J Dümichen, K Seeger, H N Lode, et al.
BMC Pregnancy and Childbirth
|
July 31, 2016
The impact of socioeconomic factors on the efficiency of voluntary toxoplasmosis screening during pregnancy: a population-based study
A E Lange, J R Thyrian, S Wetzka, et al.
Cancer Letters
|
July 26, 2003
Vaccination with minigenes encoding for novel 'self' antigens are effective in DNA-vaccination against neuroblastoma
N Huebener, B Lange, C Lemmel, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 10, 2001
A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice
R Xiang, F J Primus, J M Ruehlmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2001
Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice
R Xiang, S Silletti, H N Lode, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 26, 2000
An autologous oral DNA vaccine protects against murine melanoma
R Xiang, H N Lode, T H Chao, et al.
Page
of 5